Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 23 April 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

New sensitive assessment method for detection of vCJD

A new sensitive method for the detection of disease-related prion protein in variant Creutzfeldt Jakob disease (vCJD) is described in this week's issue of the Lancet.

News image

fiogf49gjkf04

The new technique enables the detection of prion protein in peripheral tissue, suggesting the need for new models of risk-management to prevent the spread of vCJD.

vCJD has a pattern of disease progression distinct from other forms of human prion disease.

Disease-related prion protein (PrPSc) is readily detectable in lymphoid tissues. However, quantifying the risk of secondary infection, and the targeting of risk-reduction strategies, is limited. This is due to the lack of knowledge about the relative prion concentrations in these and other peripheral tissues, the unknown prevalence of preclinical vCJD, and a transmission barrier that limits the sensitivity of biological assessment.

John Collinge and colleagues from the MRC Prion Unit, Imperial College School of Medicine, London, England, used high-sensitivity assessment to identify PrPSc distribution in a range of vCJD tissues.

Tissues were obtained from four patients at post-mortem, who had neuropathologically confirmed vCJD, and from individuals without neurological disease.

Highly sensitive analysis detected PrPSc in peripheral tissue at concentrations 104- to105-fold lower than those reported in the brain.

Tonsil, spleen, and lymph node were positive for PrPSc at concentrations in the range of 0.1-15% of those found in brain. The highest concentrations were consistently seen in tonsil.

vCJD prion proteins found in tonsil, spleen, and rectum, but not appendix.
The Lancet

PrPSc was readily detected in the retina and optic nerve of vCJD eye, at levels of 2·5% and 25%, respectively, of those found in brain.

Other peripheral tissues studied were negative for PrPSc, with the exception of low concentrations in the rectum, adrenal gland, and thymus from a single patient with vCJD.

vCJD appendix and blood were found to be negative for PrPSc.

John Collinge comments, "We have developed a highly sensitive immunoblot method for detection of PrPSc in vCJD tissues. It can be used to provide an upper limit on PrPSc concentrations in peripheral tissues, including blood, to inform risk-assessment models.

"Rectal and other gastrointestinal tissue should be further investigated to assess risk of iatrogenic transmission via biopsy instruments.

"Ophthalmic surgical instruments used in procedures involving optic nerve and the posterior segment of the eye, in particular the retina, might represent a potential risk for iatrogenic transmission of vCJD.

"Tonsil is the tissue of choice for diagnostic biopsy, and for population screening of surgical tissues, to assess prevalence of preclinical vCJD infection within the UK and other populations", he concludes.

In an accompanying Commentary, David Bolton from New York State Institute for Basic Research in Mental Retardation and Developmental Disabilities, USA, states that Collinge and colleagues' results suggest that vCJD prions may be confined primarily to tissues of the central nervous and lymphoid systems. However, he adds that many more samples, tissues, and patients need to be examined.

Lancet 2001; 358 (9277): 164, 171, 208
20 July 2001

Go to top of page Email this page Email this page to a colleague

 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure
 23 April 2018 
Sleep deprivation and NAFLD in the USA
 23 April 2018 
Antibody suitable for further clinical development to complement existing therapeutic strategies for HCV
 20 April 2018 
Obesity and physical activity in diverticulosis
 20 April 2018 
Worldwide H.pylori prevalence
 20 April 2018 
Adalimumab with azathioprine in Crohn's
 19 April 2018 
Fibrosis in patients with chronic hepatitis B
 19 April 2018 
c-Myc expression and pancreatic cancer
 19 April 2018 
Olmesartan prescription in the USA
 18 April 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 18 April 2018 
Hep C treatment for sustained virologic response
 18 April 2018 
Endoscopic necrosectomy reduces risk of death 
 17 April 2018 
Colorectal cancer screening and ethnic inequities
 17 April 2018 
Training programs should consider radiation education for advanced endoscopy fellows
 17 April 2018 
Aspirin and pancreatic cancer
 16 April 2018 
Surgery for colorectal polyps has increased 
 16 April 2018 
Advanced fibrosis can be ruled out in primary health care patients
 16 April 2018 
Antibiotic use and colorectal adenoma
 13 April 2018 
Colorectal cancer cell lines
 13 April 2018 
Infliximab and corticosteroid-free clinical remission in Crohn's
 13 April 2018 
Teduglutide for children with short bowel syndrome
 12 April 2018 
Prescriptions for opiate drugs amongst primary care patients with IBD
 12 April 2018 
Lower GI bleeding related to comorbidity
 12 April 2018 
non–Clostridium difficile bacterial infections in IBD
 11 April 2018 
Physician perception of IBD trial results
 11 April 2018 
Bile acid deficiency in IBS 
 11 April 2018 
Stem cell therapy for fistulas in Crohn's
 10 April 2018 
Overweight in childhood and type 2 diabetes
 10 April 2018 
immunoglobulin G associates with clinical features of IBD
 10 April 2018 
T-cells repertoires in celiac disease
 09 April 2018 
Biomarker tests for colorectal cancer screening
 09 April 2018 
Fecal transplantation in C. difficile infection and treatment outcome 
 09 April 2018 
No weigh-loss drug improved all cardiometabolic risk factors
 06 April 2018 
Colonoscopy and colorectal cancer mortality
 06 April 2018 
Eosinophilic esophagitis and health-related quality of life
 06 April 2018 
Microbiome in athletes vs sedentary subjects
 05 April 2018 
Laparoscopic Nissen fundoplication for GERD treatment
 05 April 2018 
Random biopsies for neoplasia in IBD
 05 April 2018 
Scoring system identifies cancer risk in Barrett's
 04 April 2018 
Alpha‐1 antitrypsin deficiency and liver disease
 04 April 2018 
PPI and risk of stroke
 04 April 2018 
Adjuvant chemotherapy for advanced colon cancer
 29 March 2018 
Prevention of metachronous gastric cancer
 29 March 2018 
Acute lower GI bleeding
 28 March 2018 
Decision aid used by IBD patients
 28 March 2018 
Transition for young adults with IBD
 28 March 2018 
Amitriptyline in functional dyspepsia
 27 March 2018 
Emergency department utilization for IBD 
 27 March 2018 
Management of hemorrhoids in the USA
 27 March 2018 
Adult ulcerative colitis
 26 March 2018 
Biological therapy response in IBD 
 26 March 2018 
Obesity and diverticulosis
 26 March 2018 
Practice guidelines for chronic constipation
 23 March 2018 
Health-related quality of life in eosinophilic esophagitis
 23 March 2018 
Genetics and chronic liver disease
 23 March 2018 
Global prevalence of H.pylori
 22 March 2018 
H. pyloris and gastric cancer
 22 March 2018 
Pancreatitis after IBS treatment 
 22 March 2018 
Mechanisms of action in patients with IBS
 21 March 2018 
Panel markers for early detection of colon cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us